| Michael E. Castagna | Chief Executive Officer | FY2022 | |
| Christopher B. Prentiss | Chief Financial Officer | FY2024 | |
| Stuart A. Tross | EVP, Human Resources | FY2024 | |
| David B. Thomson | EVP, General Counsel and Secretary | FY2022 | |
| Dominic Marasco | President, Endocrine Business Unit | Not disclosed | — |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.